New CEO, new direction: Aptim has appointed Chuck Prow as CEO and chair, effective Nov. 9, succeeding Mark Fallon, who is stepping down to pursue other ventures. Prow brings more than 30 years of leadership experience, most recently serving as CEO of V2X, a defense infrastructure and technology company with more than $4 billion in annual revenue. He will work with CFO Jon Grant and the leadership team to pursue growth opportunities in defense modernization, energy security and critical infrastructure.
Healthcare shake-up: CVS Health plans to split into two publicly traded companies by 2028, separating its 9,000 retail pharmacies from its insurance and pharmacy benefit management businesses. The move reverses its $78 billion acquisition of Aetna, with CEO David Joyner leading the insurance business and Prem Shah heading the pharmacy company. The breakup comes amid growing scrutiny of pharmacy benefit managers and efforts to streamline operations and improve profitability. CNBC has the full story.
Impact on prices: Oil prices fell nearly 2% Wednesday, with Brent crude at $101.65 per barrel and West Texas Intermediate at $94.33, as investors assessed how Democrats’ midterm election victories could affect President Donald Trump’s approach to Iran. Uncertainty over whether the U.S. will pursue diplomacy or resume military strikes has kept markets volatile, with renewed conflict potentially pushing Brent above $120 per barrel. Ongoing negotiations between Washington and Tehran and threats to shipping through the Strait of Hormuz remain key factors shaping global energy prices. The Wall Street Journal has the full story.
